Wang WN - Search Results

1

Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China.

Han YQ, Yi ZB, Yu P, Wang WN, Ouyang QC, Yan M, Wang XJ, Hu XC, Jiang ZF, Huang T, Tong ZS, Wang SS, Yin YM, Li H, Yang RX, Yang HW, Teng YE, Sun T, Cai L, Li HY, Ouyang XN, He JJ, Liu XL, Yang SE, Qiao YL, Fan JH, Wang JY, Xu BH. Han YQ, et al. Among authors: wang ss, wang jy, wang xj, wang wn. J Oncol. 2021 Sep 15;2021:6621722. doi: 10.1155/2021/6621722. eCollection 2021. J Oncol. 2021. PMID: 34567118 Free PMC article.

2

The Demographic Features, Clinicopathological Characteristics and Cancer-specific Outcomes for Patients with Microinvasive Breast Cancer: A SEER Database Analysis.

Wang W, Zhu W, Du F, Luo Y, Xu B. Wang W, et al. Sci Rep. 2017 Feb 6;7:42045. doi: 10.1038/srep42045. Sci Rep. 2017. PMID: 28165014 Free PMC article.

3

Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis.

Wang J, Xu B, Wang W, Zhai X, Chen X. Wang J, et al. Breast Cancer Res Treat. 2018 Oct;171(3):535-544. doi: 10.1007/s10549-018-4867-y. Epub 2018 Jul 4. Breast Cancer Res Treat. 2018. PMID: 29974356 Review.

4

Toremifene, rather than tamoxifen, might be a better option for the adjuvant endocrine therapy in CYP2D6*10T/T genotype breast cancer patients in China.

Lan B, Ma F, Chen S, Wang W, Li Q, Fan Y, Luo Y, Cai R, Wang J, Yuan P, Zhang P, Li Q, Xu B. Lan B, et al. Int J Cancer. 2018 Nov 15;143(10):2499-2504. doi: 10.1002/ijc.31639. Epub 2018 Sep 19. Int J Cancer. 2018. PMID: 29978573

5

Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis.

Wang J, Xu B, Wang W, Zhai X, Chen X. Wang J, et al. Breast Cancer Res Treat. 2019 Jan;173(2):487. doi: 10.1007/s10549-018-5047-9. Breast Cancer Res Treat. 2019. PMID: 30470975

6

The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China.

Lan B, Ma F, Han M, Chen S, Wang W, Li Q, Fan Y, Luo Y, Cai R, Wang J, Yuan P, Zhang P, Li Q, Xu B. Lan B, et al. Clin Breast Cancer. 2019 Apr;19(2):e370-e375. doi: 10.1016/j.clbc.2018.12.009. Epub 2018 Dec 19. Clin Breast Cancer. 2019. PMID: 30630678

7

Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers.

Yi Z, Liu B, Sun X, Rong G, Wang W, Li H, Guan X, Li L, Zhai J, Li C, Qian H, Ma F, Xu B. Yi Z, et al. Breast. 2020 Aug;52:17-22. doi: 10.1016/j.breast.2020.04.004. Epub 2020 Apr 16. Breast. 2020. PMID: 32335491 Free PMC article.

8

Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological study.

Yi ZB, Yu P, Zhang S, Wang WN, Han YQ, Ouyang QC, Yan M, Wang XJ, Hu XC, Jiang ZF, Huang T, Tong ZS, Wang SS, Yin YM, Li H, Yang RX, Yang HW, Teng YE, Sun T, Cai L, Li HY, Chen X, He JJ, Liu XL, Yang SE, Wang JY, Fan JH, Qiao YL, Xu BH. Yi ZB, et al. Among authors: wang ss, wang jy, wang xj, wang wn. Int J Cancer. 2021 Feb 1;148(3):692-701. doi: 10.1002/ijc.33227. Epub 2020 Aug 19. Int J Cancer. 2021. PMID: 32700765

9

Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer.

Yi Z, Rong G, Guan Y, Li J, Chang L, Li H, Liu B, Wang W, Guan X, Ouyang Q, Li L, Zhai J, Li C, Li L, Xia X, Yang L, Qian H, Yi X, Xu B, Ma F. Yi Z, et al. NPJ Breast Cancer. 2020 Oct 30;6:59. doi: 10.1038/s41523-020-00201-9. eCollection 2020. NPJ Breast Cancer. 2020. PMID: 33145402 Free PMC article.

10

Development and Validation of a New Clinical Prediction Model of Catheter-Related Thrombosis Based on Vascular Ultrasound Diagnosis in Cancer Patients.

Liu B, Xie J, Sun X, Wang Y, Yuan Z, Liu X, Huang Z, Wang J, Mo H, Yi Z, Guan X, Li L, Wang W, Li H, Ma F, Zeng Y. Liu B, et al. Front Cardiovasc Med. 2020 Oct 26;7:571227. doi: 10.3389/fcvm.2020.571227. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33195460 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page